« FDLI: Insights in Enforcement, Litigation & Compliance for Pharmaceutical and Medical Device Manufacturers | Main | Scope Summit Features Physician Payment Sunshine Session »

December 19, 2012

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e5520572bb8834017c3444db84970b

Listed below are links to weblogs that reference Prescription Drug Shortages: Crisis Abating - Still Need for Pricing Reform:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

Understanding economic root causation of pricing of generic drugs in shortage and the disappearance of a competitive manufacturing market has necessarily implicated questions of GPO buying monopoly powers granted previously by Congress. Unfortunately denials on their part require transparent economic data of their financial transactions with vendors before the products are acquired on their contracting systems by hospitals.Such date is presently exempt from the Sunshine Act governing all transactions between drug and device manufacturers and physicians. Physicians are now in full attention of these GPOs as a primary root cause of shortages that are externally lowering the legal meaning of patient doctor relationships from industrial economic factors external to those relationships. Prioe suprene court Opinions that our fiduciary relationshipds are protected by the US Constitution.

Michael Rie MD
University of Kentucky college of Medicine

The comments to this entry are closed.

Sponsors

Enter your Email:
Preview | Powered by FeedBlitz

December 2014

Sun Mon Tue Wed Thu Fri Sat
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31